LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
Test ordering and
ABN OnDemand, AccuDraw®, Supply Ordering, and Test Change Notification
Maturity-Onset Diabetes of the Young
The Centers for Disease Control and Prevention (CDC) estimates that more than 30 million Americans suffer from diabetes.1 Maturity-Onset Diabetes of the Young (MODY) is a form of monogenic diabetes—diabetes that results from a change or mutation in a single gene.2 While MODY only makes up about 1% of diabetes cases in the US, up to 95% of cases are misdiagnosed as Type 1 or Type 2 diabetes.2 Accurate diagnosis enables appropriate treatment.2-3
LabCorp's DoseASSURE test portfolio provides tests for both drug concentration (TDM) and anti-drug antibody (immunogenicity)
There are an estimated 84 million adults 18 years and older in the U.S. who are prediabetic or at risk for developing diabetes.1 Prediabetes is characterized as higher than normal glucose levels but not high enough to meet criteria for diabetes.2 It is associated with –
LabCorp is the exclusive national laboratory integrated within The Recovery Platform♦, allowing for seamless access to LabCorp’s medication-assisted treatment (MAT) monitoring services. The combination of LabCorp’s testing and The Recovery Platform’s software supports compliance with medication-assisted treatment, and helps patients stay on track with their recovery.
If you're interested in becoming a LabCorp customer, initiate a new account or request a visit to your office by one of our representatives to discuss our services, get started here.